Gadolinium MRI Contrast Agents and NSF

An FDA news story about MRI contrast agents using gadolinium dyes. The FDA last year added new labels to the drug regarding the risk of Nephrogenic Systemic Fibrosis (NSF). For more information see: http://www.usrecallnews.com/2007/04/gadolinium-dyes-and-nephrogenic-systemic-fibrosis-nsf.html

<< Back to article